4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000114
Chief Medical Officer sold 2,385 shares at $18.15 ($43,288)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-07-23 | Sale | −2,385 | $18.15 | $43,288 | 221,825 | D |
| Open-market sales · 2,385 sh · avg $18.15 · $43,288 | |||||||
Loading xslF345X05/wk-form4_1753477822.xml…